PLSE

NEUTRALAnalyst

Pulse Biosciences, Inc

2026-09-24

Price

$51.83

+2.41%

This is the 2026-09-24 snapshot — the signals and analysis for PLSE as of this single trading day.

View full PLSE research hub →

Score3.0Watchlist

Signals3/8 DNA0/13 Act · 2/4 Risk

SentimentNEUTRALScore: 8

Volume1.1xvs 20d avg

Analysis

Pulse Biosciences (PLSE) is experiencing High-Conviction Price Discovery driven by a fresh 'Strong-Buy' upgrade from BTIG Research and the successful enrollment completion of its PRECISE-BTN clinical study. These fundamental catalysts perfectly validate the stock's SURGE and PERFECT_STACK technical signals, which reflect a massive +47.7% relative strength outperformance against the SPY. With the macro backdrop firmly in a RISK_ON regime where ultra-tight credit spreads signal robust institutional risk appetite, the market is aggressively rewarding this pre-profitability biotech innovator.

Fired Signals

SURGEGOLDEN CROSSPERFECT STACKEXTENSIONDISTRIBUTION

Key Takeaways

Actionable Thesis: Capitalize on the institutional momentum ignited by BTIG's 'Strong-Buy' upgrade and the completed PRECISE-BTN thyroid nodule trial enrollment.
Key Risk: The stock's towering 92.8% annualized volatility and lack of free cash flow expose it to severe drawdowns if clinical progress stalls.
What to Watch: Price action around the $35.13 line-in-the-sand and any preliminary efficacy data from the 100-patient PRECISE-BTN cohort.

← Back to 2026-09-24 View Full PLSE History →Yahoo Finance &nearr;